Equity Capital Markets
Protara Therapeutics
12/25
|
$75.0 Million
Âé¶¹´«Ã½ served as bookrunner for Protara Therapeutics on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma